Publications by authors named "Jonathan Wahl"

Claim this Profile
M
Multicenter Phase I Trial of Ivosidenib as Maintenance Treatment Following Allogeneic Hematopoietic Cell Transplantation for IDH1-Mutated Acute Myeloid Leukemia.
Amir T Fathi, Haesook T Kim, Robert J Soiffer, Mark J Levis, Shuli Li, Jonathan L Wahl

Clin Cancer Res· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1 study of donor regulatory T-cell infusion plus low-dose interleukin-2 for steroid-refractory chronic graft-vs-host disease.
Jennifer S Whangbo, Sarah Nikiforow, Haesook T Kim, Jonathan Wahl, Carol G Reynolds

Blood Adv· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enasidenib as maintenance following allogeneic hematopoietic cell transplantation for IDH2-mutated myeloid malignancies.
Amir T Fathi, Haesook T Kim, Robert J Soiffer, Mark J Levis, Shuli Li, Jonathan L Wahl

Blood Adv· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of 1% Progesterone Gel to the Forehead for Ocular Chronic Graft-versus-Host Disease.
Zhonghui K Luo, Edgar A Domenech-Estarellas, Amy Han, Do Lee, Ram Khatri, Jonathan L Wahl

Transplant Cell Ther· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis